CIELO VELANDIA KELLNER: Open Payments
NPI 1770192080 · GLENVIEW, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,767 in 72 payments from 14 companies in 2025. Trend: 2023 $855 · 2024 $1,032 · 2025 $1,767
Food & beverage: $1,667Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 26 | $710 |
| ABBVIE INC. | 23 | $328 |
| Regeneron Healthcare Solutions, Inc. | 4 | $183 |
| UCB, Inc. | 6 | $151 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $106 |
| GENZYME CORPORATION | 2 | $75 |
| Amgen Inc. | 2 | $46 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $31 |
| Lilly USA, LLC | 1 | $31 |
| Galderma Laboratories, L.P. | 2 | $30 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, Bimzelx, RINVOQ, ILUMYA, OTEZLA, TALTZ.
Industry payments across IL — which companies pay providers there.
